loading

Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.35%
15.73
17.54 17.99 20.35 17.12
Operating Income/Loss
10.35%
-15.73
-17.54 -17.99 -20.35 -17.12
Nonoperating Income/Loss
46.36%
-0.644
-0.44 -0.098 -0.052 0.451
Income/Loss From Continuing Operations Before Tax
8.96%
-16.37
-17.98 -18.09 -20.40 -16.67
Income/Loss From Continuing Operations After Tax
8.96%
-16.37
-17.98 -18.09 -20.40 -16.67
Net Income/Loss
8.96%
-16.37
-17.98 -18.09 -20.40 -16.67
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.83%
45.80
44.98 44.83 0.3848 43.70
Diluted Average Shares
1.83%
45.80
44.98 44.83 0.4734 43.70
Basic Earnings Per Share
10.00%
-0.36
-0.40 -0.40 -0.46 -0.38
Diluted Earnings Per Share
10.00%
-0.36
-0.40 -0.40 -0.44 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$53.56
price down icon 1.33%
$48.34
price down icon 0.72%
$99.14
price down icon 0.31%
$154.15
price up icon 1.07%
$143.46
price down icon 2.61%
ONC ONC
$321.07
price up icon 0.46%
Kapitalisierung:     |  Volumen (24h):